These data indicate that AQB does increase the expression of CWF19L1, and that the therapeutic combination of AQB and palbociclib can effectively inhibit tumor proliferation and metastasis, which also provides a new therapeutic opportunity for glioma in the combination therapy with AQB and palbociclib. The gene discussed is CWF19L1; the disease is glioma.